Growth Metrics

Biofrontera (BFRI) Receivables - Other (2020 - 2025)

Biofrontera has reported Receivables - Other over the past 6 years, most recently at $4.8 million for Q4 2025.

  • For Q4 2025, Receivables - Other fell 9.43% year-over-year to $4.8 million; the TTM value through Dec 2025 reached $4.8 million, down 9.43%, while the annual FY2025 figure was $4.8 million, 9.43% down from the prior year.
  • Receivables - Other for Q4 2025 was $4.8 million at Biofrontera, up from $200000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $8.7 million in Q1 2022 and troughed at $56000.0 in Q3 2021.
  • A 5-year average of $3.4 million and a median of $3.4 million in 2022 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: soared 10792.86% in 2022 and later plummeted 95.38% in 2024.
  • Year by year, Receivables - Other stood at $100000.0 in 2021, then skyrocketed by 6400.0% to $6.5 million in 2022, then tumbled by 56.92% to $2.8 million in 2023, then surged by 89.29% to $5.3 million in 2024, then fell by 9.43% to $4.8 million in 2025.
  • Business Quant data shows Receivables - Other for BFRI at $4.8 million in Q4 2025, $200000.0 in Q1 2025, and $5.3 million in Q4 2024.